CNSP
CNS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.99
+2.87%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$0.24
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -42.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.24 | -$0.38 | Miss -58.33% | — |
| May 14, 2026 | -$5.37 | -$7.30 | Miss -35.94% | — |
| Mar 31, 2026 | -$5.37 | -$10 | Miss -89.01% | — |
| Nov 14, 2025 | -$6.63 | -$5.76 | Beat 13.12% | — |
| Aug 14, 2025 | -$9.60 | -$6.42 | Beat 33.13% | — |
| Nov 14, 2024 | -$0.10 | -$150 | Miss -149960.00% | — |
| Aug 14, 2024 | -$3.6K | -$4.0K | Miss -12.50% | — |
| May 15, 2024 | — | -$12.3K | — | — |
| Nov 14, 2023 | -$51.9K | -$32.4K | Beat 37.55% | — |
| Aug 14, 2023 | -$84.6K | -$31.2K | Beat 63.11% | — |
| May 15, 2023 | — | -$77.7K | — | — |
| Mar 31, 2023 | -$6.0K | -$2.23 | Beat 99.96% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026